Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.

Martins IJ.

Proteomes. 2016 Mar 31;4(2). pii: E14. doi: 10.3390/proteomes4020014.

2.

Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.

Melo TQ, van Zomeren KC, Ferrari MF, Boddeke HW, Copray JC.

Exp Brain Res. 2017 Mar;235(3):731-742. doi: 10.1007/s00221-016-4836-9. Epub 2016 Nov 19.

3.
4.

Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation.

Schirer Y, Malishkevich A, Ophir Y, Lewis J, Giladi E, Gozes I.

PLoS One. 2014 Jan 29;9(1):e87383. doi: 10.1371/journal.pone.0087383. eCollection 2014.

5.
6.

Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP).

Gozes I.

Front Endocrinol (Lausanne). 2012 Nov 16;3:134. doi: 10.3389/fendo.2012.00134. eCollection 2012. No abstract available.

7.

Strategies to defeat ketamine-induced neonatal brain injury.

Turner CP, Gutierrez S, Liu C, Miller L, Chou J, Finucane B, Carnes A, Kim J, Shing E, Haddad T, Phillips A.

Neuroscience. 2012 May 17;210:384-92. doi: 10.1016/j.neuroscience.2012.02.015. Epub 2012 Feb 23.

8.

Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1.

Fitzgerald DM, Charness ME, Leite-Morris KA, Chen S.

PLoS One. 2011;6(9):e24364. doi: 10.1371/journal.pone.0024364. Epub 2011 Sep 8.

9.

Tau as a therapeutic target for Alzheimer's disease.

Boutajangout A, Sigurdsson EM, Krishnamurthy PK.

Curr Alzheimer Res. 2011 Sep;8(6):666-77. Review.

10.
11.

HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats.

Mosch K, Franz H, Soeroes S, Singh PB, Fischle W.

PLoS One. 2011 Jan 18;6(1):e15894. doi: 10.1371/journal.pone.0015894.

12.

Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.

Braitch M, Kawabe K, Nyirenda M, Gilles LJ, Robins RA, Gran B, Murphy S, Showe L, Constantinescu CS.

Neuroimmunomodulation. 2010;17(2):120-5. doi: 10.1159/000258695. Epub 2009 Nov 17.

13.

NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).

Gozes I, Divinski I, Piltzer I.

BMC Neurosci. 2008 Dec 10;9 Suppl 3:S3. doi: 10.1186/1471-2202-9-S3-S3.

14.

Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling.

Chen S, Charness ME.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19962-7. doi: 10.1073/pnas.0807758105. Epub 2008 Dec 1.

15.

Select cognitive deficits in vasoactive intestinal peptide deficient mice.

Chaudhury D, Loh DH, Dragich JM, Hagopian A, Colwell CS.

BMC Neurosci. 2008 Jul 10;9:63. doi: 10.1186/1471-2202-9-63.

Supplemental Content

Support Center